Loading...
01/10 16:37
Loading...
Guardant Health Inc (GH) is set to release its earnings performance on 04/30 04:00:00 in After Hours trading. Consensus forecasts predict a revenue of 190.00M and an earnings per share (EPS) of -0.78 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
The earnings call summary and Q&A indicate strong revenue growth and optimistic guidance, particularly in oncology and Shield revenues. Despite some uncertainties in FDA timelines and 2026 growth, the positive reception of MCD and Guardant360's growth drivers, along with raised revenue guidance and improved margins, suggest a positive outlook. The market cap indicates a moderate reaction, leading to a 'Positive' sentiment prediction for the stock price over the next two weeks.
The earnings call summary reveals strong financial performance with significant improvements in gross profit and reduced cash flow burn. The strategic collaboration with Pfizer and raised revenue guidance are positive indicators. The Q&A section highlights growth in key products and strong market positioning, despite some uncertainties around Shield V2 data and payer coverage. The market cap suggests moderate volatility, leading to a positive prediction for the stock price movement over the next two weeks.
Despite positive revenue growth and improved gross margins, the company's increasing cash burn and lack of a share buyback program raise concerns. The Q&A section shows optimism about product development and market expansion, but management's unclear responses about market share and trial timelines add uncertainty. Given the company's market cap, the stock price is likely to remain stable, resulting in a neutral sentiment.
Guardant Health Inc (GH) is scheduled to release its FY2025Q1 earnings report onApr 30, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
Analysts' consensus predicts 190.00M in revenue and an EPS of -0.78 for Guardant Health Inc's FY2025Q1.
Intellectia's exclusive AI algorithms forecast a forGuardant Health Inc's FY2025Q1 earnings, with a prediction date of Apr 30, 2025. Guardant Health Inc
Leverage Intellectia's AI forecast to position trades ahead of theApr 30, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
Each prediction includes a detailed rationale, key indicator forecasts, and scenario probabilities to guide your trades. For a *Beat*, consider buying call options or shares; for a *Miss*, explore puts or hedging strategies. The prediction card provides actionable suggestions, like specific option strikes or hedging tips, tailored to your risk tolerance. Trade smart and turn insights into profits!
